Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Macri

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
American Journal of Obstetrics and Gynecology|October 1, 1987
Maternal serum alpha-fetoprotein screening. III. Pitfalls in evaluating black gravid womenJ N Macri, R V Kasturi, M G Hu, et al.
Annals of Clinical Biochemistry|September 1, 1994
First trimester biochemical screening for trisomy 21: the role of free beta hCG, alpha fetoprotein and pregnancy associated plasma protein AK Spencer, D A Aitken, J A Crossley, et al.
American Journal of Obstetrics and Gynecology|October 11, 1990
Maternal serum Down syndrome screening: free beta-protein is a more effective marker than human chorionic gonadotropinJ N Macri, R V Kasturi, D A Krantz, et al.
Prenatal Diagnosis|October 30, 1998
Comparison of urinary free beta (hCG) and beta-core (hCG) in prenatal screening for chromosomal abnormalitiesT W Hallahan, D A Krantz, L Tului, et al.
Annals of Clinical Biochemistry|July 1, 1993
Dual analyte immunoassay in neural tube defect and Down's syndrome screening: results of a multicentre clinical trialK Spencer, J N Macri, R W Anderson, et al.
The New England Journal of Medicine|May 9, 1996
Dimeric inhibin A as a marker for Down's syndrome in early pregnancyD A Aitken, E M Wallace, J A Crossley, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
American Journal of Obstetrics and Gynecology|October 1, 1987
Maternal serum alpha-fetoprotein screening. III. Pitfalls in evaluating black gravid womenJ N Macri, R V Kasturi, M G Hu, et al.
Annals of Clinical Biochemistry|September 1, 1994
First trimester biochemical screening for trisomy 21: the role of free beta hCG, alpha fetoprotein and pregnancy associated plasma protein AK Spencer, D A Aitken, J A Crossley, et al.
American Journal of Obstetrics and Gynecology|October 11, 1990
Maternal serum Down syndrome screening: free beta-protein is a more effective marker than human chorionic gonadotropinJ N Macri, R V Kasturi, D A Krantz, et al.
Prenatal Diagnosis|October 30, 1998
Comparison of urinary free beta (hCG) and beta-core (hCG) in prenatal screening for chromosomal abnormalitiesT W Hallahan, D A Krantz, L Tului, et al.
Annals of Clinical Biochemistry|July 1, 1993
Dual analyte immunoassay in neural tube defect and Down's syndrome screening: results of a multicentre clinical trialK Spencer, J N Macri, R W Anderson, et al.
The New England Journal of Medicine|May 9, 1996
Dimeric inhibin A as a marker for Down's syndrome in early pregnancyD A Aitken, E M Wallace, J A Crossley, et al.
Pageof 8